Compare Ascendis Pharma A/S (ASND) vs Cenovus Energy Inc (CVE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Cenovus Energy Inc — how do they compare? Ascendis Pharma A/S trades at $254.5 (market cap $16.67B), while Cenovus Energy Inc trades at $29.96 (market cap $55.00B). The key difference: Cenovus Energy Inc is far larger — about 3.3× Ascendis Pharma A/S's market cap, and Cenovus Energy Inc pays a 2.09% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | CVE | |
|---|---|---|
Market Cap | $16.67B | $55.00B |
Sector | Health | Energy |
52-Week High | $277.18 | $31.80 |
52-Week Low | $189.74 | $14.83 |
Enterprise Value | $17.04B | $61.08B |
Dividend Yield | — | 2.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Cenovus Energy Inc
Cenovus Energy is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 472 thousand barrels of oil equivalent per day in 2020, and the company estimates that it holds 6.7 billion boe of proven and probable reserves.
Read more on CVE →
